Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Manulife reports after the market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual earnings.

Historical price action around Manulife's earnings reveals moderate volatility with an upward bias. On average, the stock has moved 1.45% on earnings day (Day 0) and 3.26% the following session (Day +1), with intraday ranges averaging 2.65% and 4.10% respectively.

The most dramatic recent move came in Q4 2024, when the stock surged 4.37% on Day 0 and followed with another 3.16% gain on Day +1—a combined two-day rally of over 7%. Similarly, Q3 2025 saw a 2.65% Day 0 gain. However, 2026 has been more subdued, with Day 0 moves consistently under 1% in absolute terms, though Day +1 reactions have been more pronounced, including a 5.80% decline following Q1 results and a 5.49% drop after Q4 2025.

The pattern suggests investors should prepare for potential volatility in the session following the release, with Day +1 historically producing larger and more directional moves than the initial reaction. The average absolute Day +1 move of 3.26% indicates meaningful post-earnings price discovery is typical for MFC.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 2.05% for the November 20th expiration, which falls below the stock's average historical Day 0 move of 2.65% and significantly below the average Day +1 move of 4.10%. This suggests options traders may be underpricing potential volatility, particularly given the stock's tendency for larger reactions in the session following earnings releases.

Part 3: What Analysts Are Saying

Current Analyst Consensus: Analysts maintain a bullish stance on Manulife, with the stock carrying an average recommendation of 4.08 out of 5.0—solidly in "Buy" territory. The consensus includes 6 Strong Buy ratings, 2 Moderate Buy ratings, and 5 Hold ratings, with no sell recommendations among the 13 analysts covering the stock. The mean price target of $47.89 implies approximately 7% upside from the current price of $44.78, with a high target of $53.28 suggesting some analysts see potential for nearly 19% appreciation.

Sentiment Shift: Analyst sentiment has deteriorated modestly over the past month. The average recommendation slipped from 4.23 to 4.08, driven by one analyst downgrading from Strong Buy to Hold. The number of Strong Buy ratings declined from 7 to 6, while Hold ratings increased from 4 to 5. This shift reflects growing caution after the stock's strong year-to-date performance, with some analysts apparently taking profits or adopting a more neutral stance near 52-week highs.

Price Target Implications: Despite the recent sentiment softening, the consensus still points to modest upside potential. The $47.89 mean target represents a reasonable premium to current levels, though the range between the low target of $42.48 and high target of $53.28 illustrates meaningful disagreement about fair value. The clustering of targets in the mid-to-high $40s suggests most analysts view the current valuation as broadly appropriate, with further gains dependent on the company demonstrating sustained earnings growth and operational momentum in the quarters ahead.

Part 4: Technical Picture

Manulife enters earnings with strong technical momentum firmly intact. The Barchart Technical Opinion currently registers 100% Buy, maintaining that maximum bullish reading from the prior week and strengthening dramatically from just 48% Buy a month ago. This surge in technical conviction reflects the stock's sustained uptrend and improving momentum indicators.

Timeframe Analysis:

• Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum with no technical deterioration
• Medium-term (100% Buy): Equally strong intermediate-term reading confirms the uptrend is well-established across multiple timeframes
• Long-term (100% Buy): Maximum long-term buy signal demonstrates the broader trend structure remains firmly bullish

Trend Characteristics: The technical environment is characterized by Strong momentum that is actively Strengthening, suggesting the stock is in a robust uptrend with improving breadth and conviction heading into the earnings release.

The stock is trading at $44.78, positioned above its 20-day ($44.06), 50-day ($43.67), 100-day ($43.09), and 200-day ($40.05) moving averages—a classic bullish alignment indicating support across all major timeframes. However, the stock sits slightly below its 5-day ($44.84) and 10-day ($44.90) moving averages, suggesting minor near-term consolidation after approaching the 52-week high of $45.68 set on October 22nd.

The technical setup is highly supportive heading into earnings, with the stock in a confirmed uptrend and trading just 2% below its 52-week high. The $44.06 level (20-day moving average) represents near-term support, while the $45.68 recent high serves as immediate resistance. The strong alignment of moving averages and maximum buy signals across all timeframes suggest the stock has room to extend gains on a positive earnings surprise, though the proximity to 52-week highs means any disappointment could trigger profit-taking. The minor pullback from short-term moving averages may actually provide a healthier launch point for a post-earnings move, as it relieves some overbought pressure while keeping the broader uptrend intact.